Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

January 6, 2023

Primary Completion Date

November 1, 2025

Study Completion Date

December 31, 2025

Conditions
Acute Gout FlareGout AttackGout FlareGouty ArthritisGoutArthritisJoint Pain
Interventions
DRUG

Dapansutrile

An initial loading dose of 2000 mg dapansutrile on Day 1 followed by a maintenance regimen of 1000 mg dapansutrile twice daily starting 12 hours later through the second dose on Day 7, inclusive.

OTHER

Placebo Tablet

An initial loading dose of matching placebo (to mimic dapansutrile dosing) on Day 1 followed by a maintenance regimen of matching placebo twice daily starting 12 hours later through the second dose on Day 7, inclusive.

Trial Locations (39)

10016

RECRUITING

NYU Langone, New York

10036

WITHDRAWN

IMA Clinical Research - Manhattan, New York

16635

WITHDRAWN

Altoona Research, Duncansville

28006

RECRUITING

Hospital Universitario de La Princesa, Madrid

28031

RECRUITING

Hospital Universitario Infanta Leonor, Madrid

29486

RECRUITING

Lower Country Rheumatology - Summerville, Summerville

30501

RECRUITING

Arthritis Center of North Georgia - Gainesville, Gainesville

32256

RECRUITING

University of Florida Health Jacksonville, Jacksonville

32720

RECRUITING

Hillcrest Medical Research, DeLand

33076

RECRUITING

Centre Hospitalier Universitaire de Bordeaux - Hôpital Pellegrin, Bordeaux

33173

RECRUITING

Well Pharma Medical Research, Miami

33765

RECRUITING

Clinical Research of West Florida, Tampa

35294

WITHDRAWN

University of Alabama at Birmingham, Birmingham

40503

RECRUITING

The Research Group of Lexington, Lexington

48109

RECRUITING

University of Michigan, Ann Arbor

49100

RECRUITING

Rabin Medical Center - Beilinson and Hasharon, Petah Tikva

59462

RECRUITING

Hôpital Saint Philibert, Lomme

59808

RECRUITING

Montana Medical Research, Missoula

60462

RECRUITING

Advanced Quality Medical Research, Orland Park

60640

WITHDRAWN

Great Lakes Clinical Trials, Chicago

79124

RECRUITING

Amarillo Center of Clinical Research, Amarillo

84108

RECRUITING

Utah Health - University of Utah Hospital, Salt Lake City

85210

RECRUITING

Arizona Arthritis & Rheumatology Associates (AARA), P.C. - Mesa, Mesa

85306

RECRUITING

Arizona Arthritis & Rheumatology Associates - Glendale, Glendale

90017

WITHDRAWN

American Institute of Research, Los Angeles

91356

RECRUITING

Valiance Clinical Research - Tarzana, Tarzana

92108

RECRUITING

TriWest Research Associates, San Diego

98021

WITHDRAWN

Clinical Trial Site, Bothell

99204

RECRUITING

Arthritis Northwest, Spokane

3436212

RECRUITING

Carmel Medical Center, Haifa

5266202

RECRUITING

The Chaim Sheba Medical Center, Ramat Gan

Unknown

RECRUITING

Hôpital Lariboisière, Paris

RECRUITING

CHU de Rouen - Hôpital Charles-Nicolle, Rouen

RECRUITING

Emek Medical Center, Afula

RECRUITING

Reade Research BV, Amsterdam

RECRUITING

VieCuri Medisch Centrum, Venlo

6229 HX

RECRUITING

Maastricht Universitair Medisch Centrum, Maastricht

03010

RECRUITING

Hospital Universitario san Juan de Alicante, Alicante

08025

RECRUITING

Hospital de la Santa Creu i Sant Pau, Barcelona

Sponsors
All Listed Sponsors
lead

Olatec Therapeutics LLC

INDUSTRY